Please login to the form below

Not currently logged in
Email:
Password:

Albumedix appoints Dr Giles Campion as CMO

He brings experience from Novartis and BioMarin

Albumedix Dr Giles CampionCopenhagen, Denmark-based Albumedix has appointed Dr Giles Campion as its chief medical officer and member of the executive team.

Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform.

He brings over 25 years of drug development experience to the role, most recently as group vice president of BioMarin's neuromuscular franchise.

Prior to this, Dr Campion was both senior vice president of R&D and chief medical officer of Prosensa Holdings, served as global head of clinical R&D at General Electric Healthcare, and was European head of exploratory clinical development at Novartis.

Peter Rosholm, chief executive of Albumedix, said: “I am delighted to welcome Giles Campion to Albumedix.

“His depth of experience across a broad range of therapeutic indications, drug development track record and expertise in the filings of specialised pharmaceuticals, will be invaluable to us as we move our pre-clinical drug candidates towards the clinic.

“The appointment marks the latest step in our growth strategy as we work to advance breakthroughs in the use of albumin-based technologies in the development of life-changing therapeutics.”

16th January 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics